resveratrol has been researched along with methylprednisolone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Piao, Y; Yang, Y | 1 |
| Piao, YJ; Yang, YB | 1 |
| Altinoz, E; Ates, O; Cayli, S; Gurses, I; Kocak, A; Turkoz, Y; Yologlu, S; Yucel, N | 1 |
| Camerino, GM; Capogrosso, RF; Cozzoli, A; De Bellis, M; De Luca, A; Giustino, A; Mantuano, P; Massari, AM; Montagnani, M; Nico, B; Sblendorio, VT; Tamma, R | 1 |
| Guo, SG; Weng, XS; Wu, ZH; Zhai, JL | 1 |
| Botchway, BOA; Fang, M; Liu, X; Tan, X; Zhang, Y | 1 |
7 other study(ies) available for resveratrol and methylprednisolone
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Effects of resveratrol on Ca2+, Mg(2+)-ATPase activities after spinal cord trauma in rats].
Topics: Animals; Ca(2+) Mg(2+)-ATPase; Drugs, Chinese Herbal; Female; Male; Methylprednisolone; Rats; Rats, Sprague-Dawley; Resveratrol; Spinal Cord Injuries; Stilbenes | 2002 |
Effects of resveratrol on secondary damages after acute spinal cord injury in rats.
Topics: Acute Disease; Animals; Edema; Female; L-Lactate Dehydrogenase; Male; Malondialdehyde; Methylprednisolone; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Resveratrol; Sodium-Potassium-Exchanging ATPase; Spinal Cord Injuries; Stilbenes | 2003 |
Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury.
Topics: Animals; Glutathione; Male; Malondialdehyde; Methylprednisolone; Motor Activity; Neuroprotective Agents; Nitric Oxide; Rats; Rats, Wistar; Resveratrol; Spinal Cord; Spinal Cord Injuries; Stilbenes; Xanthine Oxidase | 2006 |
Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
Topics: Acetophenones; Animals; Antioxidants; Disease Models, Animal; Male; Methylprednisolone; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NADPH Oxidases; NF-kappa B; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Physical Conditioning, Animal; Reactive Oxygen Species; Resveratrol; Sirtuin 1; Stilbenes; Taurine | 2016 |
Effect of Resveratrol on Preventing Steroid-induced Osteonecrosis in a Rabbit Model.
Topics: Animals; Disease Models, Animal; Femur Head Necrosis; Lipopolysaccharides; Magnetic Resonance Imaging; Methylprednisolone; Plasminogen Activator Inhibitor 1; Rabbits; Resveratrol; Stilbenes; Thrombomodulin; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A | 2016 |
Resveratrol treatment of spinal cord injury in rat model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; bcl-2-Associated X Protein; Caspase 3; Disease Models, Animal; GAP-43 Protein; Inflammation; Male; Methylprednisolone; Microscopy, Electron; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Resveratrol; Spinal Cord Injuries | 2019 |